The ATTRibute-CM Trial

Talking Points
04/09/2024 6 min
The ATTRibute-CM Trial

Listen "The ATTRibute-CM Trial"

Descargar episodio Ver en sitio original

Episode Synopsis

Julian Gillmore and C. Michael Gibson discuss the efficacy of acoramidis for patients with transthyretin amyloid cardiomyopathy.
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA